COVID-19: Health Minister calls upon all scientific departments to develop enhanced synergy

Dr. Harsh Vardhan, the minister for Science and Technology, Earth Sciences and Health and Family Welfare reviewed through video-conferencing the various initiatives CSIR has taken up to mitigate COVID-19 in the country.

CSIR has devised five verticals: digital and molecular surveillance; rapid and economical diagnostics; new drugs/repurposing of drugs/vaccines; hospital assistive devices and PPE; supply chain and logistics support systems in order to develop requisite S&T-based solutions to combat COVID-19. Significant developments in each of the five verticals were presented by the vertical coordinating directors.

Dr Vardhan during video conferencing also said, “that all CSIR labs are rising to the occasion and have supported people by supplying sanitisers, masks, ready-to-eat food, apart from developing S&T-based solutions.”

He conveyed to the scientific departments, “To develop enhanced synergy and good-quality coordination for quicker and better results. All scientists and institutions should prioritise the requirements of the time and also contribute in finding quick and deployable solutions.”

“I am happy to see the enthusiasm of CSIR scientists and that CSIR has made good progress since the last review,” Dr. Harsh Vardhan said.

“This is the result of a strong partnership between National Centre for Disease Control (NCDC), New Delhi and CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), representing the largest submission of sequences, by far, from India by any group. The joint NCDC-CSIR programme will accelerate molecular epidemiology and viral surveillance efforts of India,” Dr. Harsh Vardhan further added.

A drug which has recently been approved by the United States Food and Drug Administration (USFDA) for emergency use in COVID-19 patients is also a major development from the CSIR efforts.

The guidelines were also released by the minsiter for public transport and feeder modes considering social distancing norms developed by CSIR-CRRI (Central Road Research Institute).

Dr Vardhan said, “Post COVID-19, a new normal will develop in the society, setting new standards to live in a better way, in a scientific way which will eventually become good health norms.”

DG CSIR, Dr Shekhar C Mande; Director CSIR-IGIB, Dr Anurag Agarwal; Director CRRI, Dr Satish Chandra; Director CSIR-IIIM, Dr Ram Vishwakarma; Director CSIR-IIP (Indian Institute of Petroleum), Dr Anjan Ray; and Director NAL, Jitendra Yadhav, besides directors of other CSIR labs across the country were present at the video-conference.

  • Related Posts

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

    Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

    Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    24-year-old woman dies during surgery; Five UP doctors booked for negligence

    24-year-old woman dies during surgery; Five UP doctors booked for negligence

    Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

    Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

    Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

    Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War